The DOI matches its Crossref record; 184 of the 186 references it cites were found in a registry or an index.
Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke
Open accessAbstract
BACKGROUND: Combined oral contraceptives (COCs) have been associated with an increased risk of arterial thrombosis, i.e. myocardial infarction or ischemic stroke. However, as these diseases are rare in young women and as many types of combined oral contraception exist, the magnitude of the risk and the effect of different hormonal contents of COC preparations remain unclear. OBJECTIVES: To estimate the risk of myocardial infarction or ischemic stroke in users compared with non-users of different types, doses and generations of combined oral contraception. SEARCH METHODS: We searched electronic databases (MEDLINE (1966 to July 08, 2015), EMBASE (1980 to July 08, 2015), Popline (1970 to July 08, 2015) and LILACS (1985 to July 08, 2015) for eligible studies, without language restrictions. SELECTION CRITERIA: We included observational studies that recruited women in the reproductive age group (18 to 50 years) and compared the risk of myocardial infarction or ischemic stroke between users and non-users of COCs. DATA COLLECTION AND ANALYSIS: Two review authors independently selected relevant studies and extracted data. We pooled relative risks ()(combined odds ratios and one incidence rate ratio) and 95% confidence intervals (CIs) for myocardial infarction or ischemic stroke in users versus non-users of COCs.We combined the outcomes of myocardial infarction and ischemic stroke and also analysed these outcomes separately. Analyses were stratified according to estrogen dose and progestagen type. MAIN RESULTS: In total, we identified 1298 publications through the search strategy. We included 28 publications reporting on 24 studies. COC users were at increased risk of myocardial infarction or ischemic stroke compared with non-users: relative risk (RR) 1.6 (95% CI 1.3-1.9).These RRs were similar for myocardial infarction (1.6, 95% CI 1.2 to 2.1) and ischemic stroke (1.7, 95% CI 1.5 to 1.9). The risks did not vary clearly according to the generation of progestagen or according to progestagen type. When we stratified preparations according to estrogen dose, the risk of myocardial infarction or ischemic stroke seemed to increase with higher doses of estrogen. AUTHORS' CONCLUSIONS: This meta-analysis showed that the risk of myocardial infarction or ischemic stroke was 1.6-fold increased in women using COCs . The risk was highest for pills with > 50 microgram estrogen. When combined with the results of studies on the risk of venous thrombosis in COC users, it seems that the COC pill containing levonorgestrel and 30 μg of estrogen is the safest oral form of hormonal contraception.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oral contraceptives and non-oral forms of combined hormonal contraceptives were associated with an increased risk of arteriothrombotic events (table 1).55 67 79”
From Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review (2020) · cites this paper as [55]
In the citing paper
“Current users of combined oral contraceptives had a greater risk of developing myocardial infarction and stroke than non-current users of combined oral contraceptives.55”
From Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review (2020) · cites this paper as [55]
In the citing paper
“The same review55 showed that the risk was increased in women on higher doses of oestrogen but was not related to the dose, generation, or type of progesterone (supplementary table 3).”
From Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review (2020) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981
Contraceptive failure in the United States
Trussell, J. (2011) · Contraception · doi:10.1016/j.contraception.2011.01.021 · Cited by 1,591
White, I. R., Barrett, J. K., Jackson, D., & Higgins, J. P. T. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1045 · Cited by 1,114
A Tale of Coronary Artery Disease and Myocardial Infarction
Nabel, E. G., & Braunwald, E. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1112570 · Cited by 1,024
Lifetime risks of cardiovascular disease
Berry, J. D., Dyer, A., Cai, X., Garside, D. B., Ning, H., Thomas, A., Greenland, P., Van Horn, L., Tracy, R. P., & Lloyd-Jones, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1012848 · Cited by 945
Vlieg, A. V. H., Helmerhorst, F. M., Vandenbroucke, J. P., Doggen, C. J. M., & Rosendaal, F. R. (2009) · BMJ · doi:10.1136/bmj.b2921 · Cited by 661
Self-citationCarlo, A. D., Lamassa, M., Baldereschi, M., Pracucci, G., Basile, A. M., Wolfe, C. D. A., Giroud, M., Rudd, A., Ghetti, A., & Inzitari, D. (2003) · Stroke · doi:10.1161/01.str.0000068410.07397.d7 · Cited by 644
Thrombotic stroke and myocardial infarction with hormonal contraception
Lidegaard, Ø., Løkkegaard, E., Jensen, A., Skovlund, C. W., & Keiding, N. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1111840 · Cited by 607
The Hemostatic System as a Modulator of Atherosclerosis
Borissoff, J. I., Spronk, H. M. H., & Cate, H. T. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011670 · Cited by 584
Flagged first, then by citations
2 of the 186 references couldn’t be matched to a known paper.
Research works printed but not linked: 7
- Beaumont, 1986, Oral contraception and thrombosis: implication of anti sex-steroid hormone antibodies, 1st, 190
- Lidegaard, 2001, Oral contraceptive pills and thrombosis, Ugeskrift for Laeger, 163, 4549
- Meinel, 1988, Hormonal contraception and cardiovascular risk. Results from a multicenter case-control study, Zentralblatt fur Gynakologie, 110, 1507
- Salvesen, 2000, Migraine patients and birth control pills, Tidsskr Nor Lageforen, 120, 1883
- Siegerink B Andersson HM Luken BM Crawley JT Algra A Lane DA VWF and ADAMTS13 levels and the risk of myocardial infarction and ischaemic stroke in young women: results from the ratio case-control study Journal of Thrombosis and Haemstasis: Suppl 2 2011 209.
- Sun, 2004, Risk factors for haemorrhagic stroke and oral contraceptives among Chinese women: 1:1 Case-control study, Chinese Journal of Family Planning, 12, 606
- The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014
Cited by
Sorted by citations
Items 201–297 of 297
Sex differences in neurovascular disorders
Carcel, C., Caso, V., de Sousa, D. A., & Sandset, E. C. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.07.001 · Cited by 2
Dasgupta, S., Mondal, J., Goswami, B., & Dasgupta, J. (2023) · Obstetrics & Gynecology Science · doi:10.5468/ogs.23142 · Cited by 2
Empowering access: the U.S.’ first over-the-counter birth control pill revolutionizes contraception
Sajid, F. B., Mughal, Z. U. N., Syed, N., Maalik, A., Mussarat, A., Rangwala, B. S., Zaidi, S. M. F., Rangwala, H. S., Ali, M., & Farah, A. A. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001986 · Cited by 2
Arterial thrombosis in users of contemporary hormonal contraception
Johansson, T. (2025) · BMJ · doi:10.1136/bmj.r237 · Cited by 2
Thrombophiliediagnostik in der Gynäkologie und Geburtshilfe
Scholz, U. (2019) · Der Gynäkologe · doi:10.1007/s00129-019-04512-2 · Cited by 1
Tozetto, H. C. D. M., Tiguman, G. M. B., Nicoletti, M. A., & Aguiar, P. M. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902022e21335 · Cited by 1
Vityala, Y., Garg, R., Ausvi, S. M., Shantaram, M., Tippabathini, S., Reddy, L. H. B., Jain, Y., Jaladi, P., Duvvuri, S. P., & Meduri, K. C. (2024) · Exploration of Drug Science · doi:10.37349/eds.2024.00067 · Cited by 1
Stroke in young women: the need for targeted prevention and treatment strategies
Carcel, C., Tastula, K., & Henry, A. (2024) · The Medical Journal of Australia · doi:10.5694/mja2.52516 · Cited by 1
Hormesis and brain metabolism in aging and neurodegeneration
Pereira, R. M., Albernaz-Mariano, K. A., Jucá, P. M., Juliano, V. A. L., Sampaio, L. L., & Munhoz, C. D. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.05.005 · Cited by 1
Fertility treatments and stroke: a scoping review
Moores, G., Zhang, L. M., Bui, E., & Pikula, A. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-095199 · Cited by 1
Sharifi, Z., Yousufzai, S., Akbari, M. R., Poustchi, H., Gandomkar, A., Malekzadeh, F., Qaderi, S., & Vardanjani, H. M. (2025) · Contraception and Reproductive Medicine · doi:10.1186/s40834-025-00389-w · Cited by 1
Different Methods and Routes of Administration of Hormonal Contraception
Birkhaeuser, M. H. (2026) · Reproductive medicine for clinicians · doi:10.1007/978-3-032-07322-8_9 · Cited by 1
Hypertension et grossesse. Le post-partum
Hugon‐Rodin, J., & Plu‐Bureau, G. (2016) · La Presse Médicale · doi:10.1016/j.lpm.2016.04.010 · Cited by 1
Clinical Reasoning: An unusual case of blurry vision in a young woman after ovarian induction
Parikh, N. S., Khazanova, D., Moya, A., Kaunzner, U. W., Allen, B. B., & Navi, B. B. (2016) · Neurology · doi:10.1212/wnl.0000000000002915 · Cited by 1
La contraception chez les adolescents canadiens
Meglio, G. D., Crowther, C., & Simms, J. (2018) · Europe PMC (PubMed Central) · doi:10.1093/pch/pxy001 · Cited by 1
Nair, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815846-3.00012-0 · Cited by 1
The use and impact of contraceptives in women: a critical review
David, S. C., Eze, S. C., Eleje, C. C., Odoh, E. C., Olanrewaju, O. F., Kalu, O. L., & Eze, C. C. (2022) · International Journal of Scientific Reports · doi:10.18203/issn.2454-2156.intjscirep20223039 · Cited by 1
Contraception in Systemic Lupus Erythematosus (SLE)
Shaukat, F., & Keeling, S. (2019) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-019-00136-8 · Cited by 1
Drug causes of ischaemic stroke
Burrage, D. (2019) · Adverse Drug Reaction Bulletin · doi:10.1097/fad.0000000000000041 · Cited by 1
Prevention of Stroke by Modification of Additional Vascular and Lifestyle Risk Factors
Towfighi, A., & Saver, J. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316286234.018 · Cited by 1
Ortega, M. Q., Cruz, R. S., Bernardi, L. G., Braga, M. E. D., & Dominato, A. A. G. (2020) · Research Society and Development · doi:10.33448/rsd-v9i11.10458 · Cited by 1
Oral contraceptive among risk factors for women with ischemic stroke
PALUDO, C. S., Sachetti, A., & PAIXÃO, M. S. (2021) · Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde · doi:10.30968/rbfhss.2021.121.0548 · Cited by 1
Combined Hormonal Contraceptives
Bitzer, J. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108961110.007 · Cited by 1
Joseph W. Goldzieher on the occasion of his 100th birtday
Benagiano, G., & Brosens, I. A. (2019) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2019.1653452 · Cited by 1
Acne Management in Polycystic Ovary SyndromePreprint
Dagash, R., Daghash, A., & Abu-Taha, M. I. (2020) · doi:10.22541/au.158758005.54259309 · Cited by 1
A STUDY COMPARING THE EFFECTS OF DIFFERENT ORAL CONTRACEPTIVES ON LIPID PROFILE
.Ambikadevi, R. G. A. D. K. (2014) · International Journal of Pharma and Bio Sciences
Burch, J., & Gruenebaum, D. D. (2016) · Cochrane Clinical Answers · doi:10.1002/cca.988
Black, A., Guilbert, É., Costescu, D., Dunn, S., Fisher, W. A., Kives, S. L., Mirosh, M., Norman, W. V., Pymar, H. C., Reid, R. L., et al. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.02.003
Plu‐Bureau, G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65736-7
Differenzierte Kontrazeptionsberatung bei neurologischen Grunderkrankungen
Segerer, S. E., & Keck, C. (2018) · Der Gynäkologe · doi:10.1007/s00129-018-4353-y
Infarti cerebrali del soggetto giovane
Bodenant, M., & Leys, D. (2018) · EMC - Neurologia · doi:10.1016/s1634-7072(18)41288-3
Considering Conversion: The Aftermath of Oral Contraceptives
Markette, J. A. A. F. (2018) · The Linacre Quarterly · doi:10.1177/0024363918815818
Republication de : Contraception : Recommandations pour la Pratique Clinique du CNGOF (texte court)
Chabbert‐Buffet, N., Marret, H., Agostini, A., Cardinale, C., Hamdaoui, N., Hassoun, D., Jonville‐Béra, A. ‐., Lambert, M., Linet, T., Pienkowski, C., et al. (2019) · Sages-Femmes · doi:10.1016/j.sagf.2019.01.004
RISK FACTORS OF THROMBOTIC COMPLICATIONS IN WOMEN USING COMBINED HORMONAL CONTRACEPTIVES
Vereina, N. K., Movchan, T. V., & Чулков, В. С. (2019) · Современные проблемы науки и образования · doi:10.17513/spno.28607
Hormone Replacement Therapy in Premature Ovarian Insufficiency
Bruni, V., & Pampaloni, F. (2019) · ISGE series · doi:10.1007/978-3-030-14358-9_10 · Cited by 1
Over-the-counter contraceptive pill could save the health system $96 million a year
Parkinson, B., & Mutowo, M. (2019) · doi:10.64628/aa.ghtffmhep
GAMBARAN PENGGUNAAN KONTRASEPSI HORMONAL PADA PASIEN STROKE ISKEMIK DI RSUD Dr. SOETOMO SURABAYA
Puspaningtyas, V. S., Winardi, B., & Sulistiawati, S. (2021) · Indonesian Midwifery and Health Sciences Journal · doi:10.20473/imhsj.v3i1.2019.37-50
Fertility Control in the Cardiac Patient
Briller, J. E., Johnson, M. R., & Roos‐Hesselink, J. W. (2019) · Wiley eBooks · doi:10.1002/9781119409861.ch34
de Swart, S. M. (2019) · Praktische huisartsgeneeskunde · doi:10.1007/978-90-368-2409-5_18
Contraception et maladies auto-immunes
Plu‐Bureau, G. (2020) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2020.03.018
Plu‐Bureau, G. (2020) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2020.05.016
Metabolic Syndrome and Pathogenesis of Obesity-Related Adverse Outcomes in Pregnancy
Sugimura, M. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.93144
Contraception in Perimenopausal Patients
Reeves, J. A., & Cwiak, C. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-46391-5_17
Combination Oral Contraceptive Pills
Ireland, L. D., & Allen, R. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-46391-5_2
Mamytova, E. M., Kadyrova, A., Abirova, R. E., Zholdoshev, E., MUKANBETOVA, G. D., & Dzhunushaliev, C. K. (2020) · Morphologia · doi:10.26641/1997-9665.2020.3.137-142
How to advise on safe delivery and best contraception for patients with heart failure
Johnson, M. R., & Cauldwell, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817667-2.00007-4
Contraceptive Choice in Women with PCOS
Fruzzetti, F., Fidecicchi, T., & Palla, G. (2021) · Trends in andrology and sexual medicine · doi:10.1007/978-3-030-70932-7_16
Indicaciones de la drospirenona más allá de la anticoncepción.
Hoz, F. J. E. D. L. (2021) · Revista Ciencias Biomédicas · doi:10.32997/rcb-2021-3372
Combined Oral Contraceptive Use in Young Stroke Etiology: A Case Report and Literature Review
Karadeli, H. H., Şimşekoğlu, R., Taşdemir, İ. M., & Tombul, T. (2021) · Turkish Journal Of Neurology · doi:10.4274/tnd.2020.65707
Оstroumova, Т. М., Ostroumova, O. D., & Filippova, Y. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-12-42-49
Cardiovascular medications in pregnancy
Youmans, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818902-3.00009-9 · Cited by 1
Srinivasan, M., White, A., Lott, J. P., Williamson, T. E., Kong, S. X., & Plouffe, L. (2021) · Gates Open Research · doi:10.12688/gatesopenres.13430.1
Hormonal and Non-hormonal Contraceptives
Bitzer, J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108582322.022
Cauci, S., Francescato, M. P., Colannino, C., Barbina, M., Barbina, G., & Xodo, S. (2020) · doi:10.21203/rs.3.rs-27814/v1
Bruni, V., Dei, M., & Pampaloni, F. (2020) · Endocrinology · doi:10.1007/978-3-030-03594-5_7-1
Faropoulos, K., Tsolaki, V., GEORGAKOPOULOU, V. E., Aravantinou‐Fatorou, A., & Fotakopoulos, G. (2022) · Cureus · doi:10.7759/cureus.26972
Myocardial infarction in pregnancy: Current topical issues in diagnostics and treatment
Vasilchenko, M. K., Moiseeva, A. Y., Алиджанова, Х. Г., & Викторович, Б. И. (2022) · Medical alphabet · doi:10.33667/2078-5631-2022-9-8-16
STROKE IN WOMEN: TIME TO ACKNOWLEDGE SEX DIFFERENCES
Khan, M. (2022) · Khyber Medical University Journal · doi:10.35845/kmuj.2022.22516
GUÍA FMC CONTRACEPCIÓN Y SALUD REPRODUCTIVA
Rodríguez, P. D., Manchado, B. E., & Ballesta, I. A. (2022) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2021.12.008
Contraception, Family Planning, and Pregnancy Management: The Nurse Specialist Role
Corzine, S., & Mm, C. (2022) · Springer eBooks · doi:10.1007/978-3-031-07598-8_13
EFFECT OF RESVERATROL ON NO/SH-MECHANISMS OF NEURON DAMAGE IN EXPERIMENTAL VCD-HYPOESTROGENEMIA
Zaychenko, G. V., STRYGA, O., Belenichev, I. F., GORCHAKOVA, N., & KUCHKOVSKYI, O. (2022) · Fìtoterapìâ · doi:10.33617/2522-9680-2022-2-4
EFFECT OF RESVERATROL ON NO/SH-MECHANISMS OF NEURON DAMAGE IN EXPERIMENTAL VCD-HYPOESTROGENEMIA
Zaychenko, G. V., STRYGA, O., Belenichev, I. F., GORCHAKOVA, N., & KUCHKOVSKYI, O. (2022) · Fìtoterapìâ · doi:10.33617/2522-9680-2022-2-13
Cardiovascular risk reduction in polycystic ovary syndrome
Shams, P., Ahmed, I., & Samad, Z. Z. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00027-x
Kardiyovasküler hastalığı olan kadınlarda kontrasepsiyon ve danışmanlık
Dorukoğlu, S., & Daşıkan, Z. (2023) · Androloji Bülteni · doi:10.24898/tandro.2023.66563
Contraceção hormonal combinada: o que sabem as utilizadoras sobre os seus riscos e benefícios
Mouro, M. F., Rosa, C. P., de Belmonte, C. D. S., Nunes, S., Branco, I. P. D. C., & Fonseca-Moutinho, J. A. (2023) · Revista Portuguesa de Clínica Geral · doi:10.32385/rpmgf.v39i3.13454
A Life Course Approach to Cardiovascular Disease
Masoli, J. A. H., & Hardy, R. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192864642.003.0005
Amrani, M., & Gaberle, H.-E. (2023) · Springer eBooks · doi:10.1007/978-3-662-65371-5_11
Dubynetska, V. M. (2023) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.19.4.2023.1005
A Review on Epidemiological Profile of Recurrent Congenital Clubfoot After Ponseti Correction
Chansa, C., Simpamba, M. M., & Chiluba, B. C. (2021) · doi:10.21617/book2023.1015
Contraception in Women with Cardiovascular Conditions
Cagnacci, A., Massarotti, C., Gabbi, L., & Xholli, A. (2024) · Cambridge University Press eBooks · doi:10.1017/9781108961097.022
Nelson, O. E., Simeon, G. G., Borobuebi, O. J., Wankasi, M. M., & Chukwuma, E. F. (2024) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20230060
de Venezuela, S. O. G., Centeno, I., y Metabolismo, S. V. D. E., y Osteoporosis, S. V. D. M., & Cortiñas, P. (2024) · Revista de Obstetricia y Ginecología de Venezuela · doi:10.51288/0084s105
Sex differences in ischemic stroke: risk factors, pathology, and treatment
Branyan, T. E., & Sohrabji, F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-820480-1.00115-7
Accidente vascolare cerebrale nella donna
Kaaouana, O., & Cordonnier, C. (2024) · EMC - Neurologia · doi:10.1016/s1634-7072(24)48973-3
Silva, M. A., Ferreira, B. D. S., da Silva, L. C. N., Santos, D. H., Nascimento, J. P. P., Machado, C. B. D. A., Ribeiro, E. S. G., França, M. L., de Aragão, A. B., Mangueira, P. K. C. A., et al. (2024) · Revista Foco · doi:10.54751/revistafoco.v17n7-105
Contraception et accidents artériels
Plu‐Bureau, G., & Raccah-Tebeka, B. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-78270-1.00016-8
A Case of Moyamoya Vasculopathy Presenting as Simultaneous Ischemic and Hemorrhagic Strokes
Zhong, W., Mehta, A., Haberli, N., Elmashad, A., Forman, R., & Kim, J. A. (2024) · The Neurohospitalist · doi:10.1177/19418744241299068
Maciejczyk, T., Sadowski, J., Sieńko, A., Łabuś, M., Dołęga, J., Mól, P., Zabawa, B., Hudzińska, P., Papież, Ł. S., & Krzykawski, K. (2024) · Quality in Sport · doi:10.12775/qs.2024.36.56580 · Cited by 1
Acute oral toxicity of herbo-mineral combination: Talisadi yoga in Wistar albino rats
Jaiswal, N., Karkare, M., & Divya, C. (2025) · International Journal of Ayurvedic Medicine · doi:10.47552/ijam.v15i4.5072
Plu‐Bureau, G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00192-8
Unique Patient Populations Requiring Mechanical Circulatory Support
Mosbahi, S., Siepe, M., & Mihalj, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-74963-6_22
A life course approach to cardiovascular disease
O’Keeffe, L. M., Mishra, G. D., & Hardy, R. (2025) · Oxford University Press eBooks · doi:10.1093/oso/9780198895961.003.0008
Ko, J.-H., Moon, S. J., Han, K., Kwon, H. M., Park, S.-E., Rhee, E.-J., & Lee, W. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0487
Women’s and Transgender Issues in Thrombosis and Hemostasis
Abdulrehman, J., Weyand, A. C., & Shehata, N. (2025) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2025.07.007
Tepper, N. K., Curtis, K. M., Nguyen, A. T., Zapata, L. B., Cohen, M. A., & Whiteman, M. K. (2025) · Contraception · doi:10.1016/j.contraception.2025.111209 · Cited by 1
Tegg, N. L., Semmens, J., O’Donnell, E., Myburgh, C., Hyde, A. M., Kennedy, M., & Norris, C. M. (2025) · Women s Health Reports · doi:10.1177/26884844251379434
Cardiovascular Disease After Hysterectomy in the Nurses' Health Study and Nurses' Health Study II
Huang, K. (2025) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000006057
Pan, Y., Davis, P. B., Kaebler, D. C., Blankfield, R. P., & Xu, R. (2022) · Figshare · doi:10.6084/m9.figshare.20786767
Current Available Pharmacological Interventions for PCOS: Oral Contraceptive Pills
Bashir, S., Shah, I. M., Ashraf, B., Geer, M. I., & Ganie, M. A. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810962125010005
Kantawee, K., Rattanakanokchai, S., & Kietpeerakool, C. (2025) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.70176
Lifestyle Medicine for Primary and Secondary Stroke Prevention: A Narrative Review
Tagayuna, R. Y., Rowden, C., Sherzai, D., & Sherzai, A. Z. (2026) · American Journal of Lifestyle Medicine · doi:10.1177/15598276261418006
Very low-density lipoprotein and the human health
Bharadwaj, A., Taneja, M., Dubey, S., & Saxena, A. (2026) · World Journal of Experimental Medicine · doi:10.5493/wjem.v16.i1.117024
Furuto, Y., Yoshino, D., Namikawa, A., Sato, D., & Shibuya, Y. (2026) · Hypertension Research · doi:10.1038/s41440-026-02731-4
Cardiovascular Disease Risk Factors Across Reproductive Transitions: From Menarche to Menopause
Cortés, Y. I., Khoudary, S. R. E., & Manson, J. E. (2026) · Physiology in health and disease · doi:10.1007/978-3-032-26472-5_12
Leo, V. D., Casolati, E., Rosa, S. D., Piccolo, E., & Mangrella, M. (2026) · Reproductive Medicine · doi:10.3390/reprodmed7040058
Frank, M. K., Schirmer, B., & Seifert, R. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-06003-3
Dhakne, A. N., Rajopadhye, B. D., Londhe, V. A., & Dhande, P. P. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1925241
Metadata
- Authors
- Roach, R. E. J., Helmerhorst, F. M., Lijfering, W. M., Stijnen, T., Algra, A., & Dekkers, O. M.
- Affiliations
- Leiden University Medical Center (NL)
- University Medical Center Utrecht (NL)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2015-08-27
- Volume
- 2018
- Issue
- 3
- Pages
- CD011054-CD011054
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC6494192
- OpenAlex
- W2160662478
- Cited by
- 299
- References
- 186
- Citations by year
- 2026: 10 · 2025: 31 · 2024: 34 · 2023: 20 · 2022: 50 · 2021: 33 · 2020: 36 · 2019: 25 · 2018: 27 · 2017: 16 · 2016: 14 · 2015: 2
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- combined oral contraceptives, myocardial infarction, ischemic stroke, arterial thrombosis, estrogen dose, progestogens, hormonal contraception, cardiovascular risk, young women, relative risk, estrogen-progestin combination, thrombosis risk stratification
- MeSH terms
- Contraceptives, Oral, Combined, Estrogens, Female, Humans, Myocardial Infarction, Progestins, Cohort Studies, Case-Control Studies, Risk Assessment, Stroke, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review